PT Refers to Prothrombin Time, NOT SGPT
No, PT definitively refers to prothrombin time, which is a coagulation test measuring blood clotting function, not SGPT (serum glutamic-pyruvic transaminase), which is an older term for alanine aminotransferase (ALT), a liver enzyme.
Clear Distinction Between These Tests
According to authoritative guidelines, prothrombin time (PT) and INR are assessments of blood clotting used to measure liver synthetic function, as the underlying protein clotting factors (II, V, VII, IX, and X) are made in the liver 1. This is fundamentally different from SGPT/ALT, which measures hepatocellular injury.
Prothrombin Time (PT):
- Measures coagulation function by assessing the time required for stable clot formation after adding thromboplastin and calcium to citrated plasma 2
- Reflects liver synthetic capacity—requires loss of >70% of hepatic synthetic function before prolongation occurs 1
- Used for monitoring oral anticoagulation therapy and assessing bleeding risk 2
- Can be prolonged by liver dysfunction OR vitamin K deficiency 1
SGPT/ALT (Alanine Aminotransferase):
- Measures hepatocellular injury, not synthetic function
- Part of the standard liver blood test panel that identifies the vast majority of adults with liver disease 1
- Elevated in acute liver cell damage
- Completely different clinical utility than PT 3
Common Pitfall to Avoid
The confusion likely arises from abbreviation overlap in medical terminology. Both tests are commonly ordered together as part of liver function assessment, but they measure entirely different aspects:
- PT = synthetic function (coagulation)
- SGPT/ALT = hepatocellular injury (enzyme leak)
In clinical practice, when someone writes "PT," they universally mean prothrombin time. SGPT is now more commonly referred to as ALT in modern medical practice 4, 5.